search
Back to results

Pilot Study of a Multicomponent Nurse Intervention to Reduce Delirium in Hospitalized Older Adults (MID-Nurse-P)

Primary Purpose

Delirium

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Multicomponent nurse-led intervention
Sponsored by
Complejo Hospitalario Universitario de Albacete
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Delirium focused on measuring Delirium, Pilot Study, Nurse intervention, Hospitalization

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with an age equal or older than 65 years
  • Hospitalized at the Acute Geriatric Unit of the "Complejo Hospitalario Universitario of Albacete"
  • Valid signed informed consent by the patient or legal representative.

Exclusion Criteria:

  • Agonic situation
  • Non-Spanish speaking
  • Severe cognitive decline (Reisberg´s Global Deterioration Scale = 7)
  • Patients sharing the same room with a previously included participant

Sites / Locations

  • Complejo Hospitalario Universitario de Albacete

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention Group

Control Group

Arm Description

Multicomponent nurse-led intervention (orientation, sensorial deficit, sleep, mobilization, hydration, nutrition, drugs, elimination, oxygenation, pain)

Usual care

Outcomes

Primary Outcome Measures

Delirium incidence (% participants)
Delirium incidence during hospitalization (% participants)

Secondary Outcome Measures

Mean daily delirium severity (mean score Delirium Rating Scale-Revised-98)
Mean delirium severity per day with delirium (mean score Delirium Rating Scale-Revised-98)
Mortality (% of participants)
Mortality (% of participants)
Length of stay (days)
Length of hospitalization time (days)
Restraint measures (number of participants with these measures)
Use of restraint measures for delirium control (number of participants with these measures)
Drugs for delirium (% of participants using neuroleptics or benzodiazepines)
Use of drugs (neuroleptics or benzodiazepines) for delirium control (% of participants)
Delirium prevalence (% of participants)
Delirium prevalence during hospitalization (% of participants)
Delirium severity (sum of total Delirium Rating Scale-Revised-98 socres during hospitalization)
Delirium severity during hospitalization (sum of total Delirium Rating Scale-Revised-98 socres during hospitalization)
Recruitment rate (% of patients)
% of the eligible patients recruited
Complete follow-up rate (% of participants)
% of the included participants completing the follow-up
Adherence to intervention (% of participants)
% of included participants receiving every scheduled intervention
Capacity of the team (% of participants)
% of participants that can´t complete the intervention program due to study team problems
Process time (time in minutes)
Daily time employed per participant for delivering the intervention

Full Information

First Posted
July 28, 2015
Last Updated
September 23, 2015
Sponsor
Complejo Hospitalario Universitario de Albacete
search

1. Study Identification

Unique Protocol Identification Number
NCT02558777
Brief Title
Pilot Study of a Multicomponent Nurse Intervention to Reduce Delirium in Hospitalized Older Adults
Acronym
MID-Nurse-P
Official Title
Pilot Study of a Multicomponent Nurse Intervention to Reduce the Incidence and Severity of Delirium in Hospitalized Older Adults: MID-Nurse-P
Study Type
Interventional

2. Study Status

Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
October 2013 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
February 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Complejo Hospitalario Universitario de Albacete

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Objectives: To analyze if a multicomponent nurse-led intervention randomized clinical trial (MID-Nurse Study) is feasible (Pilot study), and can reduce the incidence, duration, and severity of delirium in hospitalized older adults in an AGU. Design: Parallel-group Double-blind Randomized Clinical Trial (Pilot Study). Setting: AGU "Complejo Hospitalario Universitario from Albacete" (Albacete, Spain). Participants: 50 patients ≥ 65 years hospitalized in the AGU (21 intervention group, 29 control group). Interventions: After risk factor analysis, all participants in the intervention group (IG) received a daily multicomponent intervention (orientation, sensorial deficit, sleep, mobilization, hydration, nutrition, drugs, elimination, oxygenation, pain) by the intervention nurses. The control group (CG) received usual care. Measurements: Delirium presence was determined daily with the Confusion Assessment Method (CAM), and delirium severity with the Delirium Rating Scale-Revised-98 (DRS). Mortality, days of hospitalization, use of physical restraint measures, and use of drugs for delirium control (neuroleptics and benzodiacepines) were also recorded.
Detailed Description
Parallel-group, double blind (evaluation and analysis), randomized clinical trial (pilot study). The design was based on recommendations for conducting pilot studies (Thabane 2010). The main objective of the MID-Nurse (Randomized Clinical Trial) was to analyze if a multicomponent nurse-led intervention reduces the incidence, duration, and severity of delirium in hospitalized older adults in an Acute Geriatric Unit (AGU). Specific objectives and evaluating criteria of the MID-Nurse-P (Pilot Study) were: Process: To determine the recruitment rate (criteria: at least 70% of the eligible patients can be recruited), the complete follow-up rate (criteria: at least 85% of the included participants complete the follow-up), and the adherence to intervention (criteria: at least 80% of the included participants receive every scheduled intervention). Resources: To assess capacity of the team and process time to conduct the trial. Criteria: Less than 10% of the participants can´t complete the intervention program due to study team problems, and daily time employed per participant is not longer than 30 minutes. Management: To analyze potential study personnel and data managing problems. Scientific: To estimate the intervention effect and the variance. In the first 24 hours from admission, all the following data were collected by the evaluation nurses, once the informed consent was signed, and randomization performed by the principal investigator, who did not take part in the rest of the data collection and clinical intervention: Demographic data, Charlson comorbidity index, mean clinical diagnosis for admission, usually consumed drugs before admission, Barthel index, Holden´s FAC instrument, Pfeiffer´s Short Portable Mental Status Questionnaire, Reisberg´s Global Deterioration Scale, Dowton scale, pain with the visual analogical scale, and pressure ulcers risk with the Braden scale. Vital signs were determined on admission, including blood pressure, heart rate, temperature, hydration level, and oxygen saturation. Medical or nurse procedures were recorded, including bladder catheterization, nasogastric tube placement, venous or arterial access, blood sample acquisition, and other invasive procedures. Blood sample was collected, and haemoglobin, leukocyte and neutrophil count, reactive C protein, sedimentation rate, glucose, urea, sodium, potassium, albumin, total proteins, cholesterol, thyroid stimulating hormone, transferrin, ferritin, total iron, folic acid, and B12 vitamin, were recorded. After patient enrollment, all the patients received daily an evaluation of the Confusion Assessment Method scale (CAM) (Inouye 1990) by the evaluation nurses, in the afternoon. Prevalence of delirium throughout the follow-up was described, prevalence excluding the first day (to avoid bias of patients that were admitted with confusion), and incidence of delirium (new case across the follow-up, one patient could have more than 1 incident delirium). Number of days with delirium were also registered, and mean number of days with delirium was calculated for both groups. In the case that the CAM was positive for delirium, patients also were evaluated with the Delirium Rating Scale-Revised-98 (DRS-R-98) (de Rooij 2006) to determine delirium severity. Total delirium severity was calculated by adding the severity of delirium during all days of hospitalization, and mean severity per day was calculated dividing the global severity per number of days with delirium. Main outcome variables were the presence of delirium throughout the follow-up (dichotomic variable, yes/no), number of days with delirium during hospitalization (continuous variable), and total delirium severity (sum of DRS-R-98 during the complete follow-up). Participants in the intervention group received the first intervention in the first 24 hours from admission, and thereafter daily until hospital discharge. Participants in the control group received usual medical and nurse care during all the hospitalization process. The intervention was carried out exclusively by the "intervention nurses", and was composed of two main parts, being the first one a risk factor analysis, and the second one the intervention on the risk factors detected (orientation, sensorial deficit, sleep, mobilization, hydration, nutrition, drugs, elimination, oxygenation, pain). Furthermore, the intervention nurses identified the principal caregiver in the first 24 hours from admission, and provided an informative booklet about strategies and recommendations to prevent delirium incidence, including ambient strategies, orientation abilities, and identification of alert signs.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium
Keywords
Delirium, Pilot Study, Nurse intervention, Hospitalization

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
Multicomponent nurse-led intervention (orientation, sensorial deficit, sleep, mobilization, hydration, nutrition, drugs, elimination, oxygenation, pain)
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Usual care
Intervention Type
Other
Intervention Name(s)
Multicomponent nurse-led intervention
Intervention Description
Participants in the intervention group received the first intervention in the first 24 hours from admission, and thereafter daily until hospital discharge. The intervention was carried out exclusively by the "intervention nurses", and was composed of two main parts, being the first one a risk factor analysis, and the second one the intervention on the risk factors detected (orientation, sensorial deficit, sleep, mobilization, hydration, nutrition, drugs, elimination, oxygenation, pain). Furthermore, the intervention nurses identified the principal caregiver in the first 24 hours from admission, and provided an informative booklet about strategies and recommendations to prevent delirium incidence, including ambient strategies, orientation abilities, and identification of alert signs.
Primary Outcome Measure Information:
Title
Delirium incidence (% participants)
Description
Delirium incidence during hospitalization (% participants)
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Secondary Outcome Measure Information:
Title
Mean daily delirium severity (mean score Delirium Rating Scale-Revised-98)
Description
Mean delirium severity per day with delirium (mean score Delirium Rating Scale-Revised-98)
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Title
Mortality (% of participants)
Description
Mortality (% of participants)
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Title
Length of stay (days)
Description
Length of hospitalization time (days)
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Title
Restraint measures (number of participants with these measures)
Description
Use of restraint measures for delirium control (number of participants with these measures)
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Title
Drugs for delirium (% of participants using neuroleptics or benzodiazepines)
Description
Use of drugs (neuroleptics or benzodiazepines) for delirium control (% of participants)
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Title
Delirium prevalence (% of participants)
Description
Delirium prevalence during hospitalization (% of participants)
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Title
Delirium severity (sum of total Delirium Rating Scale-Revised-98 socres during hospitalization)
Description
Delirium severity during hospitalization (sum of total Delirium Rating Scale-Revised-98 socres during hospitalization)
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Title
Recruitment rate (% of patients)
Description
% of the eligible patients recruited
Time Frame
Up to five months
Title
Complete follow-up rate (% of participants)
Description
% of the included participants completing the follow-up
Time Frame
Up to five months
Title
Adherence to intervention (% of participants)
Description
% of included participants receiving every scheduled intervention
Time Frame
Up to five months
Title
Capacity of the team (% of participants)
Description
% of participants that can´t complete the intervention program due to study team problems
Time Frame
Up to five months
Title
Process time (time in minutes)
Description
Daily time employed per participant for delivering the intervention
Time Frame
Up to five months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with an age equal or older than 65 years Hospitalized at the Acute Geriatric Unit of the "Complejo Hospitalario Universitario of Albacete" Valid signed informed consent by the patient or legal representative. Exclusion Criteria: Agonic situation Non-Spanish speaking Severe cognitive decline (Reisberg´s Global Deterioration Scale = 7) Patients sharing the same room with a previously included participant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pedro Abizanda, MD,PhD
Organizational Affiliation
Complejo Hospitalario Universitario de Albacete (SESCAM)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Complejo Hospitalario Universitario de Albacete
City
Albacete
ZIP/Postal Code
02006
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
23992774
Citation
Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014 Mar 8;383(9920):911-22. doi: 10.1016/S0140-6736(13)60688-1. Epub 2013 Aug 28.
Results Reference
background
PubMed Identifier
25643002
Citation
Hshieh TT, Yue J, Oh E, Puelle M, Dowal S, Travison T, Inouye SK. Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis. JAMA Intern Med. 2015 Apr;175(4):512-20. doi: 10.1001/jamainternmed.2014.7779. Erratum In: JAMA Intern Med. 2015 Apr;175(4):659.
Results Reference
background
PubMed Identifier
17443600
Citation
Siddiqi N, Stockdale R, Britton AM, Holmes J. Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005563. doi: 10.1002/14651858.CD005563.pub2.
Results Reference
background
PubMed Identifier
19754498
Citation
Vidan MT, Sanchez E, Alonso M, Montero B, Ortiz J, Serra JA. An intervention integrated into daily clinical practice reduces the incidence of delirium during hospitalization in elderly patients. J Am Geriatr Soc. 2009 Nov;57(11):2029-36. doi: 10.1111/j.1532-5415.2009.02485.x. Epub 2009 Sep 15.
Results Reference
background
PubMed Identifier
26921934
Citation
Avendano-Cespedes A, Garcia-Cantos N, Gonzalez-Teruel Mdel M, Martinez-Garcia M, Villarreal-Bocanegra E, Oliver-Carbonell JL, Abizanda P. Pilot study of a preventive multicomponent nurse intervention to reduce the incidence and severity of delirium in hospitalized older adults: MID-Nurse-P. Maturitas. 2016 Apr;86:86-94. doi: 10.1016/j.maturitas.2016.02.002. Epub 2016 Feb 8.
Results Reference
derived

Learn more about this trial

Pilot Study of a Multicomponent Nurse Intervention to Reduce Delirium in Hospitalized Older Adults

We'll reach out to this number within 24 hrs